Quarterly report pursuant to Section 13 or 15(d)

Related Party Convertible Notes Receivable, At Fair Value (Details Textual)

v3.4.0.3
Related Party Convertible Notes Receivable, At Fair Value (Details Textual)
$ / shares in Units, $ in Thousands, shares in Millions
3 Months Ended
Mar. 31, 2016
USD ($)
$ / shares
shares
Related Party Transaction [Line Items]  
Convertible note, carring value | $ $ 500,000
Interest rate 12.00%
Conversion of common stock | shares 5.2
Conversion price | $ / shares $ 0.05
Theranostic Health Inc [Member]  
Related Party Transaction [Line Items]  
Convertible note, carring value | $ $ 400,000
Maturity date Feb. 28, 2017
Interest rate 8.00%
Conversion of common stock | shares 80.0
Conversion price | $ / shares $ 40.64
Conversion price, description The conversion price of the Note is subject to weighted average anti-dilution price protection if the dilutive issuances are for less than $1 million and full ratchet anti-dilution protection if the dilutive issuances are for more than $1 million.
Avant Diagnostics Inc [Member]  
Related Party Transaction [Line Items]  
Convertible note, carring value | $ $ 100,000
Maturity date Mar. 07, 2017
Interest rate 12.00%
Conversion price | $ / shares $ 0.20